Skip to main content

Bottom-line earnings miss to BPe

DRO recorded revenue from customers of $23.3m (+106% vs pcp) during the 1H24, -3% below BP estimates. Gross margin (71.6%) was largely in-line with BPe however opex (-$22.7m) was materially greater than our estimates (-$18.5m) and was the primary reason for the miss at the bottom line. This included share-based payment expenses of -$2.7 million, an increase of 207% relative to 1H23 of -$0.8m. DRO recorded EBITDA of -$5.2m (vs BPe -$1.1m) and a net loss after tax of -$4.8m (vs BPe -$1.6m), excluding the share-based payment expense the net loss after tax was $2.1m. The company had a cash balance of $230m as of 23-Aug-24, with no core debt or convertibles.

Focus remains on 2H

The company entered the 2H with a contracted backlog of $32m and sales pipeline of $1.1b, including 33 projects valued over $5m each and the largest valued at $213m. We remain confident the company will deliver a significantly improved 2H performance based on 1) the significant level of inventory on hand to facilitate rapid fulfilment, 2) the historical seasonality of the business with >80% of CY23 revenue recorded in the 2H and 3) numerous near-term sales opportunities, including recently announced military aid packages (see previous report 22-Jul-24).

Investment View: 8% increase in PT to $1.35

We have made no changes to our revenue forecasts at this stage, whilst we have made minor changes to operating expenses, cash flows and working capital in-line with today’s result. Our EPS changes are -6% and +2% in CY24 and CY25, respectively. We have reassessed our valuation assumptions and determined they are overly conservative considering the well capitalised balance sheet (we made no changes post the recent capital raise) and the recent re-rating of mid-cap defence peers. As such, we have increased the multiples we apply in our EV/EBITDA and PE valuations to 26x and 36x, respectively. The net result is an 8% increase in our PT to $1.35, which is >15% premium to the share price so we retain our buy recommendation.

To read the full report click the button below.

View Detailed Report
Authored by Daniel Laing – Analyst – at Bell Potter Securities, 27 August 2024
Important Disclaimer—This may affect your legal rights: Because this document has been prepared without consideration of any specific client’s financial situation, particular needs and investment objectives, a Bell Potter Securities Limited investment adviser (or the financial services licensee, or the proper authority of such licensee, who has provided you with this report by arrangement with Bell Potter Securities Limited) should be consulted before any investment decision is made. While this document is based on the information from sources which are considered reliable, Bell Potter Securities Limited, its directors, employees and consultants do not represent, warrant or guarantee, expressly or impliedly, that the information contained in this document is complete or accurate. Nor does Bell Potter Securities Limited accept any responsibility to inform you of any matter that subsequently comes to its notice, which may affect any of the information contained in this document. This document is a private communication to clients and is not intended for public circulation or for the use of any third party, without the prior approval of Bell Potter Securities Limited. In the USA and the UK this research is only for institutional investors. It is not for release, publication or distribution in whole or in part to any persons in the two specified countries. This is general investment advice only and does not constitute advice to any person.
Disclosure of Interest: Bell Potter Securities Limited receives commission from dealing in securities and its authorised representatives, or introducers of business, may directly share in this commission. Bell Potter Securities and its associates may hold shares in the companies recommended.